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Abstract 
Previous studies have shown that neurons in the ventral tegmental area 
(VTA) and substantia nigra (SN) project to the ventrolateral periaqueductal gray 
(PAGvl) and dorsal raphe nucleus (DR). Research has also shown that 
stimulation of neurons in the VT AISN elicits cardiovascular depressor responses 
that are mediated by a projection to the PAGvi/DR. Anatomical and physiological 
experiments were done in the present study to determine the neurochemical 
identity of the VT AISN projection to the PAGviiDR Experiments were done to 
characterize the origin and chemical nature of this projection by combining 
cholera toxin B tracing with immunofluorescence for the 67K isoform of glutamic 
acid decarboxylase (GAD) and tyrosine hydroxylase (TH). The PAGvi/DR region 
was found to receive a substantial input from neurons in the VT A, SN, and deep 
mesencephalic nucleus. The DR was preferentially innervated by neurons in the 
VTA whereas the PAGvl was preferentially innervated by neurons in the SN. A 
proportion of neurons in the VT A and the reticular part of the SN found to project 
to the PAGvi/DR were GAD positive. In addition, experiments were done in 
urethane-anesthetized rats to determine if injections of a GABA antagonist in the 
region of the PAGvi/DR attenuated the cardiovascular depressor responses 
produced by glutamate stimulation (0.01 M, 50 nl) of the VTAISN. Injections of 
the GABA blocking agent picrotoxin (2.5 nmol, 500 nl) into the PAGvi/DR 
eliminated the cardiovascular responses from stimulation of the VT AISN. The 
m 
results of the present investigation provide evidence for a GABAergic projection 
from the VT AISN to the PAGvi/DR. This projection may be an important 
regulator of the PAGviiDR, an area of the midbrain involved in the production of 
behavioral and physiological responses to pain and stress. 
Key words: ventral tegmental area, substantia nigra, periaqueductal gray, dorsal 
raphe nucleus, dopamine, GABA, cardiovascular 
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Chapter 1 
Introduction 
1.1 General Physiological Functions Associated with the 
Ventral Tegmental Area and Substantia Nigra 
1 
The ventral tegmental area (VT A) and substantia nigra (SN) are areas of 
the ventral midbrain that contain the neurotransmitter dopamine. Midbrain 
dopamine neurons are known to innervate many regions of the forebrain where 
dopamine, released from fiber terminals, functions as a neural modulator of 
forebrain neurotransmission (Mogensen and Yang, 1991; Yang et al., 1999). The 
VT A and SN are also composed of other neuronal types, some of which use 
gamma-aminobutyric acid (GABA) and neuropeptides as neurotransmitters or 
modulators. 
The dopaminergic projections to the forebrain have been implicated in a 
number of functions related to the behavioral and motor responses associated 
with the survival of organisms. It is generally accepted that dopamine released in 
the basal ganglia exerts an activating or permissive action on motor movements 
2 
(Alexander et al., 1990; Aflfi, 1993). The most obvious indication of dopamine's 
role in movement is that loss of dopamine neurons in the SN as seen in 
Parkinson's disease causes rigidity, hypokinesia, and tremors. Treatment with 
the dopamine precursor l-DOPA or with dopamine receptor agonists stops the 
tremors, allows movement to occur, and reduces rigidity in Parkinsonian patients. 
Dopamine release in the ventral striatum has also been implicated in the initiation 
of locomotion, and may form part of the motivational drive needed for behavior to 
occur (Mogensen and Huang, 1973; Mogensen and Yang, 1991). Midbrain 
dopamine neurons are also important for motivation and reward mediated 
behaviors. For example, dopamine neurons in the vr A, which innervate the 
ventral striatum and limbic cortex, are thought to be involved in the preparation, 
organization and initiation of goal-directed behaviors. In particular, dopamine 
neurons of the vr A are an integral part of the natural reward circuitry (Schultz, 
1998, 2000, 2002), and have been implicated in the behavioral sensitization and 
the dependence produced by several drugs of abuse including commonly abused 
drugs such as heroin, alcohol, cocaine and amphetamine (Bonci et al., 2003). 
Changes in dopamine function may be, in part, related to mood disorders such as 
depression and cognitive disorders such as schizophrenia (Yang et al., 1999). 
3 
1.2 Possibility of Other Functions for the VT A and SN 
In addition to the well-recognized influence of the dopamine neurons in the 
vr A and SN on movement and motivation, the vr A and SN are likely to have 
other important functions. It has been suggested that the VT A and SN are 
involved in an organism's reactivity to changes in the environment, for selective 
information processing and for general emotional responses, which are essential 
for an organism to cope with the external world (Pani et al., 2000). For example, 
it is well known that exposure of an organism to a challenging or novel 
environment (so called stress) results in an increase in the metabolism and the 
release of dopamine in limbic structures and the basal ganglia (Finlay and 
Zigmond, 1997; Feenstra, 2000; Pani et al., 2000). This increase in dopamine 
release may help in the selection of the appropriate behavioral and physiological 
responses to challenges in the environment (Mogenson and Yang, 1991; Kirouac 
and Ganguly, 1992, 1995). In addition, there are numerous studies supporting a 
role for both the VT A and the SN in pain modulation. Injections of morphine or 
other pharmacological agents into the VT A and SN have been shown to elicite 
antinociception in a variety of behavioral tests (Juma et al., 1978; Barnes et al., 
1979; Baumeister and Frye, 1986; Frye et al., 1986; Baumeister et al., 1987, 
1988, 1989, 1990, 1993; Hebert et al., 1990; Morgan and Franklin, 1990; 
Baumeister, 1991; Altier and Stewart, 1993, 1996, 1997, 1998), and lesions of 
the vr A have been shown to result in an increase of pain response or 
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hyperalgesia (Saade et al., 1997; Sotres-Bayon et al., 2001 ). Previous studies 
have also shown that stimulation of the vr A and SN with the excitatory amino 
acid l-glutamate elicits decreases in arterial pressure (Kirouac and Ciriello, 
1997b; Zhang et al., 1997; Kirouac and Pittman, 2000). While speculative at this 
time, it is possible that the vr A and SN are involved in the regulation of 
physiological responses associated with motor and behavioral responses to the 
challenges in an organism's environment 
1.3 Anatomical Organization of the Ventral Midbrain 
1.3.1 Ventral Tegmental Area and Substantia Nigra (VTAISN) 
Many of the anatomical details of the ventral midbrain are based on the 
location of dopamine neurons, which form the major type of neuron in this region. 
Figure 1 shows the location of different subdivisions of the VTA and SN through 
their rostrocaudal extent. The SN lies in the ventral tegmentum of the 
mesencephalon, and is a heterogeneous collection of neurochemicaily and 
functionally interrelated elements. Anatomically, the SN consists of three major 
parts (Fallon and Loughlin, 1995). The substantia nigra pars compacta (SNC) is 
located ventrally to the medial lemniscus and dorsally to the substantia nigra pars 
reticulata (SNR). The SNC is composed of a sheet of dopamine neurons that are 
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Fig.1. Photomicrograph of a section of the ventral midbrain showing tyrosine 
hydroxylase immunohistochemically positive neurons that are concentrated in the 
ventral tegmental area and substantia nigra. The substantia nigra is composed 
of the compact part where dopamine neurons are found; reticular part, which is 
composed mostly of GABA neurons; and lateral part, which consists of dopamine 
and GABA neurons. The deep mesencephalic nucleus is considered the 
reticular formation containing dopamine neurons mixed with GABA neurons. 
VT A, ventral tegmental area; SN, substantia nigra; SNC, compact part of the 
substantia nigra; SNR, reticular part of the substantia nigra; SNL, lateral part of 
the substantia nigra; DpMe, deep mesencephalic nucleus; ml, medial lemniscus. 
DpMe 
• 
ml 
SNR 
7 
known as the A9 dopamine cell group as first described by Dahlstrom and Fuxe 
(1964). The SNR is a pallidal structure formed by GABA neurons with small 
clusters of dopamine neurons found in various regions of the SNR. lateral to the 
SNC and SNR is the substantia nigra pars lateralis (SNL), which contains another 
group of dopamine neurons and some non-dopaminergic neurons (Moriizumi et 
al., 1992). As described above, the SN is populated by dopamine neurons in the 
SNC (Bjorklund and Lindvall, 1975) and GABA neurons in the SNR. Dopamine is 
one of the major neurotransmitters found in neurons of the SN. It has been 
estimated that about 90% neurons in the SNC and SNL are dopaminergic 
(Swanson, 1982). Gonzalez-Hernandez and Rodriguez (2000) also reported that 
nearly 20% of the total population of dopamine neurons in the VT AISN are 
located in the SNR. 
The VTAwas classically described by Tsai (1925a, b) from Golgi and Nissl 
preparations. The VT A lies in the midline on the floor of the midbrain and 
contains a large number of dopamine neurons (more than 80%) known as the 
A 1 0 dopamine cell group (Swanson, 1982) interspersed with GABA neurons 
{Oades and Halliday, 1987; Fallon and Loughlin, 1995). The dopamine neurons 
in the lateral part of the VT A merge with dopamine neurons of the SNC without a 
clear boundary between the two structures (see Fig. 1). Furthermore, it is widely 
agreed that the VT A is subdivided into several distinct cytoarchitectural regions 
such as parabrachial pigmented nucleus, paranigral nucleus, rostral linear 
nucleus and caudal linear nucleus, and interfasicular nucleus (Dahlstrom and 
Fuxe, 1964; Palkovits and Jacobowitz, 1974; Phillipson, 1979b; Oades and 
Halliday, 1987; Fallon and Loughlin, 1995; Gonzalez-Hemandez and Rodriguez, 
2000). The subregions of the VT A innervate different regions of the forebrain and 
thalamus (Oades and Halliday, 1987). However, there is considerable overlap in 
these innervation pattems and the fundional significance of the different 
subdivisions of the VT A remains unknown. 
1.3.2 Neurotransmitters in the Ventral Midbrain 
1.3.2.1 Dopamine 
It was recognized as early as the 1950's that dopamine may play an 
important role in neurotransmission when several investigations demonstrated 
that dopamine was present in the brain and that it was especially concentrated in 
the basal ganglia (Weii-Maiherbe and Bone, 1957; Montagu, 1957; Carlsson et 
al., 1958; Carlsson, 1959; Bertler and Rosengren, 1959a,b). In the 1960's, 
Swedish scientists described the presence of the major ascending dopamine 
systems that originate from dopamine neurons in the VTA and SN (Carlsson et 
al., 1962; Dahlstrom and Fuxe, 1964; Fuxe, 1965; Anden et al., 1966; Fuxe et al., 
1970; Ungerstedt, 1971 ). Since those early studies, numerous other studies 
have been done to map the central dopamine neuronal system using 
histofluorescence techniques and tyrosine hydroxylase (TH) 
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immunohistochemistry (Dahlstrom and Fuxe, 1964; Hokfelt et al., 1974, 1976, 
1980; Halasz et al., 1977; Fuxe et al., 1978; Moore and Bloom, 1978; Lindvall, 
and Bjorklund, 1978; Lindvall, and Bjorklund, 1983). Morphologically, there are 
four distinct ascending pathways (Fuxe, 1985; Oades and Halliday, 1987): 1) the 
nigrostriatal system, which originates from the SNC and projects to the dorsal 
striatum; 2) the mesolimbic system, which originates from the VT A and sends 
projection to the ventral striatum; 3) the mesolimbic-cortical system, which 
originates from the VT A and innervates the septum, amygdala and limbic cortex; 
4) the mesothalamic system, which originates mainly from the medial VT A and 
activates medial thalamus associated with the limbic system (Troiano and 
Siegel, 1978; Phillipson, 1979a; Phillipson and Griffith, 1980; Tork et al., 1984). 
These ascending dopamine neurons project to their targets through two major 
fiber systems, the medial forebrain bundle which contains dopamine fibers that 
innervate the striatum and limbic system, and the periventricular fiber system 
which innervates the thalamus region. 
1.3.2.2 GABA 
The other major type of neuron in the vr A and the SN is the GABA 
neuron, which forms a population of intemeurons and projection neurons. GABA 
neurons in the SN are densely concentrated in the SNR and are distributed 
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sparsely in the SNl and SNC. GABA neurons in the SNR project to the thalamus, 
superior collirulus and pedunrulopontine nucleus (Dahlstrom and fuxe, 1964; 
Kilpatrick et al., 1980; Childs and Gale, 1983; Williams and Faull, 1985; Chiodo, 
1988; Hedreen and Delong, 1991; Parent and Hazrati, 1995). The SNR and the 
globus pallidus share morphological and chemical similarities {Delong and 
Georgopoulos, 1979; Afifi, 1993), and serve as major output structures of the 
basal ganglia. Both structures project massively to specific thalamic relay nuclei, 
namely the ventral anterior and ventral lateral nuclei, which in tum project to the 
cerebral cortex (Alexander and Crutcher, 1990; Parent and Hazrati, 1995). 
The VT A is composed of approximately 15-20% neurons that are non-
dopaminergic (Mugnaini and Oertel, 1985, Kalivas, 1993; Fallon and loghlin, 
1995). These neurons are in dose proximity to dopamine neurons and are 
believed to be GABA intemeurons (Nagai et al., 1983; Otterson and Storm-
Mathisen, 1984; Mugnaini and Oertel, 1985, Kalivas, 1993). However, it has also 
been demonstrated that a population of VT A neurons retrogradely labeled from 
the nucleus accumbens and the prefrontal cortex contains GABA (Van 
Bockstaele and Pickel, 1995; Carr and Sesack, 2000). The GABA projection 
neurons may form a portion of the mesolimbic-oortical pathway and play a role in 
regulating the activity of dopamine neurons implicated in behavioral 
reinforcement (Steffensen et al., 1998, 2001). In other words, the VTA GABA 
neurons are not only local inhibitory neurons but also projection neurons that 
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send axons to the oortex and nucleus accumbens, and potentially other areas of 
the brain. 
1.3.2.3 Neuropeptides 
Despite the fact that dopamine and GABA are found in the majority of 
neurons of the VTA and SN, several neuropeptides have also been localized 
within neurons of the ventral midbrain. Neurons immunoreactive for the 
neuropeptides neurotensin and cholecystokinin are also immunoreactive forTH, 
a marker for dopamine neurons in the midbrain (Seroogy et al., 1988). Neurons 
found to oontain neurotensin or cholecystokinin are always found to be 
dopaminergic, which means that neurons of the VTAISN never use 
cholecystokinin or neurotensin exclusively as neurotransmitter (Seroogy et al., 
1988). The physiological implication of co-localization of peptides with dopamine 
remains somewhat controversial. Nevertheless, neuropeptides are likely to be 
oo-released with dopamine and probably function in the regulation of dopamine 
release or act on neurotensin or cholecystokinin receptors in terminal fields of 
dopamine neurons (Seroogy et al., 1988). 
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1.3.2.4 Acetylcholine 
In Mesulam's comprehensive mapping of acetylcholine neurons in the 
brain, there was no mention of cholinergic neurons in the VT A and SN (Mesulam 
et al., 1984). On the other hand, using choline acetyltransferase (ChAT) 
immunohistochemistry, several studies have shown the existence of a small 
number of cholinergic neurons in the caudal SN (Sofroniew et al., 1985; Woolf 
and Butcher, 1985; Gould and Butcher, 1986; Moriizumi et al., 1991) as well as 
the dorsal and lateral parts of the middle caudal levels of the SNR, particularly in 
the borders of the SNC, SNR and SNl (Gould and Butcher, 1986; Martinez-
Murillo et a/., 1989). These weakly stained ChAT -positive neurons are thought to 
be projection neurons that innervate the superior colliculus. It has also been 
suggested that cholinergic neurons may play an important role in the regulation of 
forebrain activation and locomotion (Gould and Butcher, 1986; Martine:z-Murillo et 
al., 1989; Moriizumi et a/., 1991 ). 
1.3.3 Descending Projections from the VTAISN 
In addition to these well-koown ascending dopaminergic and GABAergic 
projections of the VTAISN, there is some evidence for descending projections to 
the locus ooeruleus, lateral parabrachial nucleus, cerebellum and the 
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periaqueductal gray (Beckstead et al., 1979; Simon et al., 1979; Ouimet et al., 
1984; Fuxe et al., 1985). It must be emphasized that the chemical nature of 
descending projections from the vr A and SN is not known. However, dopamine 
fibers and terminals have been demonstrated in those brainstem regions with 
immunohistochemical techniques (Kitahama et al., 2000). Dopamine receptors 
have also been demonstrated in these brain regions (Kirouac and Ganguly, 
1992). The chemical nature of descending projections from the VT A and SN to 
the brainstem would have to be examined using retrograde tract-tracing 
techniques combined with immunohistochemistry for neurotransmitters such as 
dopamine. Therefore, the details of these descending projections remain largely 
unexplored. 
1.4 Role of the Ventral Midbrain in Cardiovascular Regulation 
1.4.1 Ventral Tegmental Area and Substantia Nigra (VTAISN) 
As previously described, dopamine pathways are generally thought to 
function in the regulation of motor and behavioral responses mediated by 
neuronal mechanisms in the forebrain (Kohler et al., 1985; Alexander et al., 
1990). However, recent experimental evidence suggests that the mesencephalic 
dopamine system may play an important role in the regulation of the 
14 
cardiovascular system. For example, some dopamine neurons in the VTA were 
found to respond to baroreceptor activation produced by systemic injections of 
the adrenoreceptor agonist phenylephrine (Kirouac and Ciriello, 1997 a). 
Stimulation of the VT A electrically or with microinjection of the excitatory amino 
acid l-glutamate has been shown to elicit variable changes in arterial pressure 
(AP) and heart rate (HR) in the rat and rabbit (Dahlstrom and Fuxe, 1964; Oades 
and Halliday, 1987; Cornish et al., 1997; Stotz-Potter and Benarroch, 1998). 
Similarly, electrical stimulation of the SN in the cat (Beitz, 1982; Angyan, 1989; 
Bouthenet et al., 1991) or the rat ( Otake et a!., 1994) elicited increase in AP and 
HR. In addition, chemical stimulation of the SN with relatively high 
concentrations and large volumes of l-glutamate or kainic acid was reported to 
elicit responses in the rat similar to those elicited by electrical stimulation (Otake 
eta!., 1994). It was suggested that the cardiovascular responses to stimulation 
of the VT A and SN were mediated by dopamine projections because these 
responses were blocked by the peripheral and central administration of a 
dopamine antagonist (Dahlstrom and Fuxe, 1964; Otake et al., 1994; Cornish et 
al., 1997). 
The location of the neurons in the ventral midbrain that may be 
responsible for these cardiovascular responses was not clearly defined in these 
studies for two reasons. First, the large microinjections of neuroactive 
substances used to produce cardiovascular responses (Dahlstrom and Fuxe, 
1964; Otake et al., 1994; Cornish et al., 1997; Stotz-Potter and Benarroch, 1998) 
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may have stimulated neurons outside the vrA or SN. Seoond, electrical 
stimulation used to elicit the cardiovascular responses in the VT AISN may have 
activated fibers that oourse through this region (Domesick, 1988; Fallon, 1988; 
Fallon and Loughlin, 1995). Kirouac and Ciriello (1997b) systematically explored 
the ventral midbrain for cardiovascular-responsive sites by injecting small 
volumes of the excitatory amino acid L-glutamate, which has been shown to 
selectively excite neuronal cell bodies but not fibers of passage (Goodchild et al., 
1982). This study demonstrated that L-glutamate stimulation of the VTA and SN 
elicited decreases in mean AP (MAP) that were often accompanied by decreases 
in HR (see Fig.2 for example). Systemic administration of the muscarinic 
receptor antagonist atropine, which blocks the parasympathetic stimulation of the 
heart, did not alter the magnitude of the cardiovascular responses. 
Administration of the nicotinic receptor antagonist hexamethonium bromide, 
which blocks the sympathetic stimulation of the vasculature and heart, abolished 
the MAP responses and significantly attenuated the HR responses. This 
suggests that the cardiovascular responses elicited from the VTAISN are 
mediated by inhibition of the sympathetic activity to the vasculature and the heart. 
Stimulation of the VT A and SNC consistently elicited the most marked 
cardiovascular responses, while regions immediately adjacent to VT A and SNC 
had smaller effects. As shown in Figure 2, the largest depressor responses were 
elicited when the microinjections of L-glutamate were in the region where 
dopamine neurons are located in the VTA and SNC (Kirouac and Ciriello, 1997b). 
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Fig. 2. Representative micropipette tract through the region of ventral 
mesencephalon involving the ventral tegmental area (A) and the substantia nigra 
(B) showing the arterial pressure (AP) and heart rate (HR) responses elicited 
during microinjection of L-glutamate at different dorsoventral sites (filled circles). 
Note that the magnitude of the cardiovascular depressor responses elicited from 
stimulation of the prerubral field increases as the micropipette tract approaches 
the ventral tegmental area, at which point the largest cardiovascular responses 
are elicited (A). The largest cardiovascular responses in the ventral 
mesencephalon were elicited from the region of the compact part of the 
substantia nigra, whereas no responses were elicited by stimulation of reticular 
part of the substantia nigra or reticular formation of dorsal tegmentum (B). 
Arrows, time of L-glutamate injection. VTA, ventral tegmental area; SNC, 
compact part of the substantia nigra; SNR, reticular part of the substantia nigra; 
PR, prerubral field; ml, medial lemniscus. Figures are produced from Kirouac 
and Ciriello (1997). 
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Moreover the depressor responses elicited by stimulation of the VT A appear to 
involve dopamine 02 receptors because pretreatment with the 02 dopamine 
antagonist raclopride attenuated the depressor responses from stimulation of the 
VTA (Kirouac and Ciriello, 1997b). Therefore, dopamine is a possible candidate 
for mediating the cardiovascular responses produced by the VTAISN (Oades and 
Halliday, 1987). 
It is known that the VT AISN projects to many forebrain regions that have 
been implicated in the regulation of the cardiovascular system (Oades and 
Halliday, 1987). Efferent fibers from the VTAISN travel through the medial 
forebrain bundle and the periventricular fiber system to innervate the forebrain 
and thalamus. The local anesthetic lidocaine was microinjected in the ascending 
fiber bundles to chemically block nerve impulse traffic to determine the pathway 
mediating the cardiovascular depressor responses elicited from stimulation of the 
VTAISN. Bilateral microinjection of lidocaine in either the medial forebrain bundle 
or the periventricular fiber system did not attenuate the depressor responses from 
stimulation of the VTAISN, which indicated that the VTAISN depressor responses 
were not mediated by ascending projections to the forebrain. In an attempt to 
determine the relay for the VT AISN cardiovascular responses, Kirouac and 
Pittman (2000) injected the sensitive anterograde tracer biotinylated dextran 
amine in the VTAISN. The brainstem was then examined to see if the VTAISN 
projected to brainstem areas involved in the oontrol of the autonomic nervous 
system. A dense bilateral projection was found to innervate the PAGvl and the 
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lateral wing of the OR (Kirouac and Pittman, 2000), regions that have been 
strongly implicated in cardiovascular oontrol (Bendler et al., 1991; Carrive and 
Bendler, 1991; Bendler and Shipley, 1994; Dampney, 1994; Sun, 1995). 
Subsequent experiments showed that blockade of neuronal transmission with 
lidocaine or blockade of synaptic transmission with oobalt chloride in the 
PAGvi/DR region attenuated the cardiovascular depressor responses produced 
by stimulation of the VT AISN (Kirouac and Pittman, 2000). This series of 
experiments indicated that the depressor responses produced by stimulation of 
the VTAISN were mediated by a relay to the PAGvi/DR. A low to moderate 
number of dopamine 02 receptors have also been demonstrated in the PAG 
using the sensitive in situ hybridization method (Weiner et al., 1991). However, 
there is no evidence in the literature that dopaminergic neurons in the VT A 
project to the PAG or that exogenous dopamine in the PAG produces 
cardiovascular responses. 
1.4.2 Periaqueductal Gray and Dorsal Raphe Nucleus (PAGIDR) 
1.4.2.1 Midbrain Mechanisms in Analgesia and Cardiovascular Regulation 
The periaquedudal gray (PAG) is a midbrain structure that is located 
around the central canal from the posterior commissure to the rostral locus 
ooeruleus. Considerable evidence supports an important role for the PAG in the 
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regulation of defensive behaviors, autonomic fundion and pain transmission 
(Lovick, 1993; Bandler and Shipley, 1994; Behbehani, 1995). On the basis of the 
results of chemical and electrical stimulation studies, Bandler and colleagues 
proposed that the PAG consists of fundionally distind longitudinal columns that 
mediate specific physiological responses (Canive, 1991; Lovick, 1993; Sandler 
and Shipley, 1994; Behbehani, 1995; Bandler et al., 2000). For example, 
stimulation of the dorsal lateral column of the PAG with excitatory amino acids 
produces attack responses whereas stimulation of the lateral column of the PAG 
produces flight behavior. Hypertension, tachycardia and a non-opioid analgesia 
are produced from stimulation of the dorsolateral and lateral PAG. In contrast, 
stimulation of the ventrolateral column of the PAG (PAGvl) produces freezing 
behavior or hyporeadivity with hypotension, bradycardia and opioid mediated 
analgesia. The dorsal raphe nucleus (DR), which is composed of serotonin 
neurons, is in part embedded in the caudal portion of the PAGvl. The DR has 
also been implicated in nociceptive and cardiovascular regulation (Robinson et 
al., 1986; Connor and Higgins, 1990; Wang and Nakai, 1994) and is believed to 
play an important role in regulating the neural circuitry in the PAG mediating 
emotional readions to fear and pain (Lovick, 1993). 
The PAG receives afferents from a large number of brain regions 
implicated in the regulation of emotions and the physiological responses 
associated with emotional readions (Bandler and Shipley, 1994; Behbehani, 
1995). The brain regions with the most prominent projedions to the PAG and DR 
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include the limbic cortices~ hypothalamus, amygdala, dorsal hom of the spinal 
cord and variety of brainstem regions associated with the regulation of the 
autonomic and somatic nervous system (Sakai et al., 1977; Marchand and 
Hagino, 1983; Beitz, 1982; Peyron et al., 1995; Floyd et al., 2000). Recent 
experiments by Kirouac and Pittman (2000) showed that the PAG and DR were 
innervated by the VfA and SN, two areas that are also implicated in the 
regulation of behavioral and motor functions. 
1.4.2.2 PAG Mediated Hypotensive Responses 
A large amount of literature has accumulated on the role of the PAG in 
regulating emotional expression and cardiovascular function (Bandler et al., 
1991; Carrive and Sandler, 1991; Sandier and Shipley, 1994; Oampney, 1994; 
Behbehani, 1995; Sun, 1995). Studies using local microinjections of excitatory 
amino acids to selectively activate neurons in the PAG have revealed two 
functional longitudinal columns of cells that .produce distinctive cardiovascular 
responses (Bandler and Shipley, 1994) as mentioned above: stimulation of the 
lateral PAG (PAGI) produces hypertension and tachycardia while stimulation of 
the ventrolateral PAG (PAGvl) produces hypotension and bradycardia (Lovick, 
1993; Bandler and Shipley, 1994). Acute hypotensive episodes were found to 
increase the expression of c~fos in the PAGvl, indicating that neurons in the 
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PAGvl are activated by unloading of the baroreceptors (li and Dampney, 1995; 
Murphy et al., 1995; Tassoreli and Joseph, 1995). It is interesting to note that the 
hypotension and bradycardia produced by stimulation of the PAGvl are also seen 
in response to severe blood loss and pain (Schadt and ludbrook, 1991; Bruehl et 
al., 1999). Indeed, the PAGvl stands out as a region of the brain where neurons 
are excited by deep somatic and visceral nociceptive inputs and may be involved 
in the production of cardiovascular responses to pain (Bandler and Shipley, 
1994). In summary, previous experiments suggest that the PAGvl is a critical 
brain region in which deep pain and haemorrhage inputs may be integrated to 
produce hypotension and bradycardia. 
1.4.3 Descending Connections from the PAGvl Mediating Hypotension and 
Antinociception 
Figure 3 shows a schematized summary of the circuitry involved in PAGvl 
induced antinodception and hypotension. PAGvl induced antinociception and 
hypotension are mediated by a direct excitatory projection to rostral ventromedial 
medulla, caudal ventrolateral medulla and the A5 noradrenergic cell group 
located in the pons (Basbaum and Fields, 1984; Fields et al., 1991; Behbehani, 
1995). The rostral ventrolateral medulla and AS cell group project directly to the 
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Fig.3. Schematized summary of the circuitry involved in ventrolateral 
peliaqueductal gray (PAGvl) induced antinociception and hypotension. PAGvl 
induced antioociception and hypotension are mediated by a direct excitatory 
projection to rostral ventromedial medulla, caudal ventrolateral medulla and the 
AS noradrenergic cell group located in the pons. The rostral ventrolateral 
medulla and AS cell group project directly to the dorsal horn of the spinal cord 
where transmission of nociceptive information is inhibited. The rostral 
ventrolateral medulla and the AS cell group also project to preganglionic 
sympathetic neurons in the intermediolateral cell column and activation of these 
descending pathways can produce vasodilation in the circulation by inhibiting 
preganglionic sympathetic motor neurons. Neurons in the caudal ventrolateral 
medulla in tum innervate the intermediolateral cell column. The PAGvl also 
receives direct input from nociceptive neurons and this input serves as a 
feedback circuit, which when activated, produces descending inhibition of 
nociceptive transmission at the level of the spinal cord and cardiovascular 
responses. PAGvl, ventrolateral periaqueductal gray; rVlM, rostral ventrolateral 
medulla; cVlM, caudal ventrolateral meduf!a; IMl, intermediolateral cell column; 
DH, dorsal hom of the spinal cord. 
PAGvl 
+ 
+ ... 
cVLM --•• rVLM 
~.....-.................... .......__....,...+ rVMM 
A5 group 
Nociceptive input 
DH 
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dorsal hom of the spinal oord where transmission of nociceptive information is 
inhibited (Basbaum and Fields, 1984; Fields et al., 1991; Behbehani, 1995). The 
rostral ventrolateral medulla and the AS cell group also project to preganglionic 
sympathetic neurons in the intermediolateral cell oolumn and activation of these 
descending pathways can produce vasodilation in the circulation by inhibiting 
preganglionic sympathetic motor neurons (Dampney, 1994; Sun, 1995). Neurons 
in the caudal ventrolateral medulla in tum innervate the intermediolateral cell 
oolumn. The PAGvl also receives direct input from nociceptive neurons and this 
input serves as a feedback circuit, which when activated, produces descending 
inhibition of nociceptive transmission at the level of the spinal oord and 
cardiovascular responses (Bandler and Shipley, 1994). As shown schematically 
in Figure 3, sensory neurons in the dorsal hom of the spinal oord and trigeminal 
sensory nucleus as well as neurons in the central gray of the spinal oord project 
directly to the PAGvl providing an anatomical substrate for the transmission of 
nociceptive information to the PAGvl (Keay et al., 1997). The PAGvl also 
receives a strong input from the nucleus of the solitary tract and parabrachial 
nucleus, which relay visceral nociceptive and baroreceptive information to the 
brain (Clement et al., 1996). 
An anatomical projection between the VTAISN and the PAGvi/DR is of 
potential importance because of the reports indicating that the VT AISN plays a 
significant role in modulating pain and arterial blood pressure, two functions that 
are regulated by the PAGvi/DR. Several studies have also implicated the VTA 
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and SN in cardiovascular regulation. For example, stimulation of the VT A and 
the SN with excitatory amino acids produces cardiovascular depressor responses 
in anesthetized rats (Kirouac and Ciriello, 1997b; Zhang et al., 1997; Kirouac and 
Pittman, 2000), which appear to be mediated by a direct projection to the 
PAGvi/DR (Kirouac and Pittman, 2000). While the hypothesis that 
antinociception elicited by activation of neurons in the VT AISN may be mediated 
by a projection to the PAG or DR has not been tested, it is plausible considering 
the existence of a moderately dense projection between the VTAISN and PAG as 
well as the role the PAG plays in the modulation of pain transmission. 
1.5 Hypothesis 
In a recent paper, Kirouac & Pittman (2000) demonstrated a functional link 
between the VTAISN and the PAGvi/DR region by showing that the 
cardiovascular depressor responses elicited by stimulation of the VT AISN region 
were attenuated by blocking impulse transmission to the PAGvi/DR region. 
Previous anatomical studies have demonstrated a connection between the 
VTAISN and the PAGviiDR (Sakai et al., 1977; Beckstead et al., 1979; Simonet 
al., 1979; Marchand and Hagino, 1983; Kalen et al., 1988; Beitz, 1982; Peyron et 
al., 1995). However, a detailed description of the projection with consideration 
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given to the anatomical and functional columns of the PAG was not done in these 
studies. Kirouac and Pittman (2000) using the sensitive anterograde tracer 
biotinylated dextran amine confirmed that the PAGvi/DR received a dense 
projection from the VT AISN. However, the locatioo of the neurons in the VT AISN 
that project to the PAGviiDR could not be discerned by injections of biotinylated 
dextran amine that often involved several anatomically distinct subregions of the 
VT AISN (Kirouac and Pittman, 2000). Despite the potential importance of a 
connection between these midbrain regions, the connection between the VT AISN 
and the PAGvi/DR has not been the subject of detailed anatomical studies. 
The experiments in this thesis are based on the hypothesis that a 
dopaminergic projection from the VT A and SN to the PAGvi/DR mediates the 
cardiovascular depressor responses produced by stimulation of the VTAISN. 
The hypothesis is derived from the following observations: 
1. the most effective sites for eliciting cardiovascular depressor responses 
are in the VTA and SN where dopamine neurons are located (Kirouac 
and Ciriello, 1997b). 
2. blocking of dopamine 02 receptors with an intravenous injection of a 
02 antagonist attenuates the cardiovascular depressor responses 
(Kirouac and Ciriello, 1997b). 
3. dopamine neurons form the majority of projection neurons in the VTA 
and SNC (Fuxe et al., 1985; Follan and Loughlin, 1995). 
28 
1.6 Objectives 
The aims of the present study were: 
1. to describe the projections of the VT A and SN to functionally distinct 
regions of the PAGvl including the DR. 
2. to examine if other subdivisions of the PAG also receive innervation 
from the VTAISN. 
3. to determine if the neurotransmitter content of the projection is 
dopamine or GABA 
4. to determine if the cardiovascular depressor responses elicited by 
stimulation of the VT AISN are mediated by dopaminergic or 
GABAergic projection neurons. 
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Chapter 2 
Methods and Materials 
2.1 Animals 
The experimental protocols for this research were according to the 
guidelines set by the Canadian Council on Animal Care and the research 
protocols were approved by the Internal Animal Care Committee of Memorial 
University of Newfoundland. 
Male adult Sprague-Dawley rats weighing 275 to 450 g were used for the 
experiments. The animals were housed in the animal care unit and kept on a 12 
hours light and dark cycle. 
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2.2 Tract .. tracing Experiments 
A major aim of the work presented in this thesis was to describe the 
connections between the VT AISN and the PAG region. This was done by 
injecting the retrograde tracer cholera toxin B (CTb) into various regions of the 
PAG of the rat Following a sufficient period of time for the CTb to be taken up by 
fiber terminals and retrogradely transported to neurons in the VTAISN, the rat 
was perfused with fixative, brain tissue was rut and processed for CTb 
immunohisto-chemistry to visualize the location of VT AISN neurons projecting to 
the PAG. Another major aim of this thesis was to determine the neurotransmitter 
used by the VTAISN projection to the PAG region. Therefore, a second series of 
double-labeling experiments were done using immunohistochemistry or 
immunofluo-rescence combined with retrograde tract tracing with CTb or 
FluroGold (FG). Injections of CTb and FG were done in the PAG as before and 
tissue was immunoreacted for tyrosine hydroxylase (TH) or glutamic acid 
decarboxylase (GAD) to visualize the tracer and the putative neurotransmitter 
(dopamine or GABA). The following tract-tracing experiments were done: 
1. CTb tract-tracing alone (reacted immunohistochemically with DAB). 
2. CTb combined with TH and GAD immunohistochemistry (DAB reacted). 
3. FG combined with GAD immunofluoresescence (fluorescence). 
4. CTb combined with TH and GAD immunofluorescence (fluorescence). 
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2.2.1 Injection of Tracers 
Rats were anesthetized with equithesin (0.3 ml/100g body weight, i.p.) and 
given supplementary doses (0.15 ml/100g body weight, i.p.) as needed during the 
surgical procedure. Rats were placed in a Kopf stereotaxic frame with the incisor 
bar set at 3.3 mm below the interauralline (Paxions and Watson, 1986). The 
body temperature was monitored and maintained at 35-37 oc with a heating pad. 
A burr hole of approximately 1 mm in diameter was made for the injection. Glass 
micropipettes with fine tip diameters were used to iontophoretically inject the 
retrograde tracers in the PAG region. Glass micropipettes (1.00 mm i.d., 1.50 
mm o.d.; Garner Glass Company, Claremont, CA) were heated and pulled with a 
vertical pipette puller (David Kopf Instruments, Tujunga, CA), and tips were 
broken to a certain diameter (15-25 1-1m), which were verified with a microscope 
fitted with a micrometer. 
The coordinates used for injection of tracers in the caudal PAGvl were 1.5 
to 2.0 mm anterior to the interaural line, 1.0 mm lateral to the midline, and 5.0 to 
5.5 mm below the dorsal surface of the brain. Control injections were also done 
outside the PAGvl by making adjustments to the above coordinates. The scalp 
incision was sutured and rats were returned to individual cages for recovery 
during which they were closely monitored for signs of pain or distress. 
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2.2.1.1 Cholera toxin B (CTb) Injection 
Fine glass pipettes (15-25 ~m tip diameter) were used to inject CTb. The 
low salt version of CTb was reconstituted with distilled water to make a solution of 
0.5% in 0.1 M sodium phosphate buffer (list Biological Laboratory, Campbell, 
CA). The iontophoretic injections of CTb were done by applying a 3 to 5 IJA 
positive current (200 ms pulses at 2 Hz for 10 to 20 min) through a chlorinated 
silver wire placed in the pipette. 
2.2.1.2 FluroGold (hydroxystilbamidine methanesulfonate) Injection 
Glass micropipettes (20.25 !Jm tip diameter) were used to inject FluroGold 
(FG). A 0.5-1% solution of FG (Molecular Probes, Inc., Eugene, OR, USA) was 
made by dissolving 10 mg of FG in 1-2 ml of 0.1 M cacodylate buffer. The 
iontophoretic injections were done by applying a 4 to 5 1JA positive current (200 
ms pulses at 2 Hz for 20 to 30 min) or 2 1JA positive current (7 seconds on/off for 
15 min) through a chlorinated silver wire placed in the pipette. It is more difficult 
to produce dense injections of FG by iontophoresis than it is for CTb (personal 
experience). This problem was addressed by doing injections with a 7s on/off 
protocol, which seems to give injections that were denser than with the 200 ms 
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pulses protocol. The on/off current application prevents the pipette tip from being 
blocked during the application of a direct electrical current. 
2.2.2 Colchicine Treatment for GAD Immunohistochemistry 
To increase the detectable levels of GAD in the cell body of neurons, rats 
that had previously received CTb injections in the PAG/DR were treated with 
colchicine 1 to 2 days before perfusion with fiXative. Rats were anesthetized with 
equithesin (0.3 mil1 OOg body weight, i.p.) and placed in a stereotaxic frame as 
described in the previous section. A solution of 50 to 100 llg of colchicine (6 !J.I, 
Sigma) was injected into the lateral ventricles. The coordinates for this injection 
was 1.3 mm posterior to bregma, 0.8 mm lateral to the midline, and 3.0 to 3.5 mm 
below the dorsal surface of the brain. The colchicine solution was microinjeded 
by the application of pressurized nitrogen pulses controlled by a pneumatic pump 
(Medical Systems, Great Neck, NY) using a micropipette with the total volume of 
20 Ill (Division American Hospital Supply Corporation, Miami, Fla) and the tip 
diameter around 75 tJm. The scalp incision was sutured and rats were returned 
to individual cages for recovery. 
Colchicine is a well-known chemical that has been used to interrupt axonal 
transport. After injection of colchicine, newly synthesized proteins stay in the cell 
body where they are synthesized instead of being transported to the axonal 
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terminals. Therefore, with the treatment of colchicine, GAD proteins will 
accumulate in the cell body, which then could be detected more easily (Ribak et 
al., 1978). 
2.3 Perfusion and Tissue Processing 
After a survival period of 7 to 14 days, rats were deeply anesthetized and 
perfused with 150 ml of saline containing 0.5% heparin followed by 500 ml of ice-
cold fixative composed of 4% paraformaldehyde and 0.05% glutaraldehyde in 0.1 
M phosphate buffer (pH 7.4). Brains were removed and posffixed in the same 
fixative at room temperature for 1 hr before being transferred to a 20% sucrose 
solution and stored at 4°C overnight for cryoprotection. 
Coronal sections of the midbrain were cut at 25 to 50 tJrn using a freezing 
microtome (Leitz Wetzlar) or a cryostat (Uitrapro 5000, Vibratome, St. louis, MO) 
and collected in PBS prior to the immunohistochemical reaction. Some brain 
tissue processed for CTb immunohistochemistry was cut at 50-75 !Jm using a 
vibratome (Vibratome, St. louis, MO). All sections processed for immunohisto-
chemical detections of CTb or putative neurotransmitters were reacted on free-
floating sections. All antibodies were diluted in 0.1 M PBS containing normal 
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donkey serum (5 to 10%), 0.01-0.3% Triton X-100 and 0.1% sodium azide. Once 
all chemical reactions were complete, the sections were mounted on gelatin-
coated slides, dried at room temperature, and coverslips were applied using 
Fluka DPX mountant. 
2.3.1 CTb Immunohistochemistry (DAB) 
Following rinses in PBS (3 x 10 min), sections were incubated in goat anti-
CTb (1:10,000 to 40,000; catalog number 703, list Biological laboratory, 
Campbell, CA) at 4°C for 1 to 2 days. Sections were rinsed and incubated in 
biotinylated donkey anti-goat (1:500, catalog number 705-065-147, Jackson 
lmmunoResearch, West Grove, PA) for 2 hrs followed by rinses and 1 hr 
incubation at room temperature in a avidin-biotin complex according to kit 
directions (Elite ABC Kit, Vector laboratories, Burlingame, CA). This was 
followed by three rinses, incubation in diaminobenzidine for 2.5 to 10 min 
according to kit directions (DAB peroxidase substrate kit, Vector laboratories, 
Burlingame, CA). After several rinses, sections of the PAG were mounted on 
gelatin-coated slides. 
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2.3.2.1 Antibodies for Neurotransmitter Identification 
Two TH antibodies were used for these experiments. The rabbit anti-
tyrosine hydroxylase antibody (catalog number AHP368, Serotec, Raleigh, NC) 
was a polyclonal antibody that gave dark cell body staining at a high 
concentration (1 :200 to 1 :500). The monoclonal mouse anti-tyrosine hydroxylase 
(catalog number 12K4863, Sigma), in contrast, was used in a very low 
concentration (1:40,000), which resulted in dark cell body labeling with a much 
lower background staining. Most of the immunofluorescent experiments were 
with the monoclonal anti-TH antibody. 
There were three different GAD antibodies that were used for the 
experiments in this thesis: rabbit anti-glutamate decarboxylase (GAD) polyclonal 
antibody (catalog number AB108, Chemicon International, Temecula, CA); rabbit 
anti-glutamate decarboxylase66167 (GAD65167) polydonal antibody (catalog number 
AB1511, Chemicon International, Temecula, CA), which recognizes both 
isoforms of GAD (GADIM7) thereby labeling GAD in both fiber terminals and cell 
bodies (Esdapez et al., 1994; Dirkx et al., 1995); rabbit anti-glutamate 
decarboxylase67 (GAD67) polyclonal antibody (catalog number 228485, Alpha 
Diagnostic, San Antonio, TX, USA). In addition, several clones of a new 
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monoclonal GAD antibody (samples received from Chemioon International) were 
also used. Discussion on the use of these various GAD antibodies is presented 
in the Results section. 
2.3.2.2 Double-labeling Experiments for Immunohistochemistry (DAB) 
Sections were first reacted for CTb as described in section 2.3.1, but 
instead of being mounted on slides, the sections of the vr AISN were incubated 
in rabbit anti-TH (1:500; Serotec, Raleigh, NC) or rabbit anti-GAD (1:500; 
Chemioon International, Temecula, CA) at 4°C for 1 to 2 days. Sections were 
rinsed and incubated in biotinylated donkey anti-rabbit (1 :500; catalog number 
711-065-152, Jackson lmmunoResearch, West Grove, PA) for 2 hrs. After 
several rinses and 1 hr incubation in an avidin-biotin oomplex (Elite ABC Kit, 
Vector laboratories, Burlingame, CA) at room temperature, sections were rinsed 
and incubated in diaminobenzidine without Nickel solution for 2.5 to 10 min (DAB 
peroxidase substrate kit, Vector laboratories, Burlingame, CA). After rinses, 
sections were mounted and the slides were ooverslipped. 
2.3.2.3 Double--labeling Experiments for Immunofluorescence 
FG Experiments Combined with GAD Immunofluorescence 
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Antibodies for GAD were diluted in 0.1 M PBS containing 10% normal 
Donkey serum. Free-floating sections were pre-incubated in the buffer for 30 to 
60 min, and incubated in rabbit anti-glutamate decarboxylase (GAD; 1 :500; 
catalog number AB1511, Chemicon International, Temecula, CA) at 4°C for 2 
days. After rinses, brain sections were incubated in Cy3 conjugated donkey anti-
rabbit (1 :500; Jackson lmmunoResearch, West Grove, PA) for 3 hours at room 
temperature. After a few more rinses, tissue sections were mounted on slides 
and coverslipped. FG is a substance that fluoresces under an ultraviolet (UV) 
filter and therefore no further procedure is needed to visualize FG labeled cells or 
injection sites. 
CTb Experiments Combined with TH and GAD Immunofluorescence 
The tissue for CTb and TH or GAD double labeling was reacted in a 
mixture of goat anti-CTb (1 :10,000 to 40,000; list Biological laboratories, 
Campbell, CA) and monoclonal mouse anti-TH (1:40,000, Sigma) or monoclonal 
mouse anti-GAD (1 :500; Chemicon International, Temecula, CA) at 4°C for 1 to 2 
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days. This GAD antibody recognizes the 67K isoform of GAD that is preferable 
for labeling cell bodies (Esdapez et a!., 1994; Dirkx et al., 1995). After rinses, 
brain sections were incubated in another mixture of antibodies containing Cy2 
conjugated donkey anti-goat (1:500; Jackson lmmunoResearch, West Grove, 
PA) and Cys conjugated donkey anti-mouse (1:500; Jackson lmmunoResearch, 
West Grove, PA}. After a few more rinses, tissue sections were mounted on 
slides and coverslipped. 
Triton X-100 was used at a relatively low concentration of 0.01% in the 
blocking buffer for experiments to show GAD positive neurons because high 
concentrations of Triton X-100 results in the preferential labeling of GAD in fiber 
terminals. A low concentration of Triton X-1 00 is necessary for CTb antibodies to 
penetrate sufficiently (unpublished observations). At a concentration of 0.01% 
Triton X-100, both GAD and CTb immunofluorescence could be carried out on 
the same tissue sections (personal experience). 
Control experiments were done by removing the primary antibody against 
CTb, TH, and GAD, which resulted in the absence of the labeling observed when 
the immunochemical reactions were done with the primary antibody present. 
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2.4 Analysis of CTb, TH and GAD Immunohistochemistry 
Coronal sections from the caudal region of the PAG to the rostral region of 
the VT AISN were examined using a light microscope. The location of the CTb 
injection site was defined and the distribution of retrogradely labeled cells was 
analyzed. In some representative cases, the location of CTb-labeled neurons 
that resulted from injections of CTb in the different regions of the PAG was drawn 
using a drawing tube. Double-labeled neurons were analyzed with an Olympus 
fluorescent microscope (BX51) equipped with appropriate filter cubes for Cy2 (U-
MNB2, Olympus), Cy3 (U-MNG2, Olympus) or combination narrow green and 
blue filter (U-M51006ZZ, Olympus) combined with a blue/green excitation 
balancer (U-EXBABG, Olympus) to optimize the contrast under the single filter 
cube. The number of retrogradely labeled cells (CTb+) that are also labeled for 
TH (TH+) or GAD (GAD+) was counted to determine the contribution of the 
putative neurotransmitters to the innervation of the PAGviiDR Counts were done 
bilaterally on four representative sections that represented the rostrocaudal 
extent of the VTA and SN (approximate levels represented in Fig. 6B, 6C, 60, 6E 
the result section) in 4 rats that had CTb injections confined the PAGvl and 
wings of the DR. Counts were classified according to the approximate area in 
which the CTb+ neurons were found, including the VTA, SNC, SNR and SNL. 
Photomicrographs were produced using a digital camera (Spot RT Slicer, 
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Diagnostic Instruments, Sterling Heights, Ml) and the images were imported into 
Adobe Photoshop 5.5 for oontrast and oolor enhancement. 
2.5 Physiological Experiments 
Experiments were done on 1 0 male Sprague-Dawley rats (300-450 g) 
that were anesthetized using urethane (1.6 glkg, i.p.). Polyethylene catheters 
(PE-50) were inserted into the femoral artery and vein for the recording of arterial 
pressure and the administration of drugs, respectively. Rectal temperature was 
monitored and maintained at 35-37°C with a heating pad. Experiments were 
done with rats placed in a stereotaxic frame with the nose bar adjusted 3.3 mm 
below the interaural line according to the stereotaxic atlas of Paxinos and Watson 
(1986). 
Arterial blood pressure was reoorded using a pressure transducer 
(Ml T1 050; AD Instruments, Mountain View, CA} connected to a bridge amplifier 
(Ml110; ADinstruments). The electronic signal for arterial pressure was digitized 
using a Powerlab 4SP device and software (AD Instruments) and the data were 
captured and analyzed on a oomputer (Chart 4.0 data capture and analysis 
software; ADinstruments). Heart rate was calculated online from the pressure 
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pulse and the mean arterial pressure (MAP) was calculated as the diastolic 
pressure plus one-third of the pressure pulse. 
Glass micropipettes with tip diameters of 30-50 !Jm containing a 0.01 M 
glutamate (sodium salt, Sigma) dissolved in 0.1M PBS were lowered in the 
ventral midbrain on the right side (5.0-5.5 mm caudal to bregma, 0.8-1.3 mm 
lateral to the midline, and 6.5-8.5 ventral to the dura), and 50 nl of the glutamate 
solution were microinjected by the application of pressurized nitrogen pulses 
controlled by a pneumatic pump (Medical Systems, Great Neck, NY). The 
injected volumes were measured by the direct observation of the fluid meniscus 
in the micropipettes with an engineering microscope fitted with a micrometer 
(Titan, Buffalo, New York). Regions of the VTAISN were stimulated with 
glutamate to locate sites that produced depressor responses of at least 15 
mmHg. A minimal distance of 300 1Jm separated each injection site. 
It was previously established that injection of the vehicle in the VT AISN 
does not produce changes in arterial pressure or heart rate (Kirouac and Ciriello, 
1997; Zhang et al., 1997; Kirouac and Pittman, 2000). The cardiovascular 
depressor responses to glutamate microinjections into the VT A were retested 
after administration of the GABA blocking substance picrotoxin (2.5 nmol/500 nl; 
Sigma) in the region of the PAGvi/OR. Glass micropipettes (50 to 75 1Jm tip) 
were used to microinject picrotoxin with pressure pulses (8.0 mm posterior to 
bregma; 0.5 mm lateral to the midline; 5.0 mm ventral to the dura; angled 6° in 
the posterior direction). The following protocol was used: 
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1) a site in the VT A/SN that produced a depressor response of a 
minimum of 15 mmHg was identified; 
2) 15 min later, picrotoxin was injected in the PAGvi/DR; 
3) the VTA site was restimulated at 5, 30, and 60 min after the 
picrotoxin injection. 
Only one experiment was done in each animal, which was followed by 
transcardial perfusion of 100 ml saline followed by 200 ml of 1 0% formalin 
solution. Sections of the brain were cut on a cryostat and stained with thionin to 
verify the placements of the micropipettes in the VT A/SN and the PAGvi/DR. The 
effects of administration of picrotoxin in the PAGvi/DR on the depressor 
responses were analyzed using two-way analysis of variance (ANOVA) with 
repeated measures for time combined with post-hoc analysis using Tukey's 
multiple comparison tests. A P value of < 0.05 was taken to indicate a statistical 
difference. Values are expressed as means ± standard error of the mean. 
Chapter 3 
Results 
3.1 Retrograde Tracing of the VT AISN Projection to the 
PAGvi/DR 
3.1.1 Appearance of the CTb Injection Site 
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The center of the CTb injection site was darkly stained while the periphery 
appeared less intensive with a high density of granule and some fibers emanating 
from the injection site. The sites were generally round or ovoid and slightly 
variable in size as shown in Figure 4A. The diffusion of the CTb in brain tissue 
(the size of the injection site) is restricted by the density of cell bodies, the 
presence of blood vessels, and the location of fiber bundles within the injected 
regions. For example, the relatively cell dense region of the PAG limits the 
amount of diffusion of the CTb from injections in that area. 
Tract-tracing experiments require the investigator to produce small but 
dense injections of tracers within a limited area of brain tissue. Iontophoretic 
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Fig. 4. Schematic diagram showing the location of cholera toxin B injections in 
the periaqueductal gray region and the dorsal raphe nucleus for the 
immunohistochemical tract-tracing experiments (A) or the double labeling 
immunofluorescence experiments (B). Numbers represent the anterioposterior 
levels of Paxinos and Watson. DR, dorsal raphe nucleus; PAGdl, dorsolateral 
periaqueductal gray; PAGvl, ventrolateral periaqueductal gray. 
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injections are well suited for this, but the ability to make successful injections of 
CTb by iontophoresis can be unreliable. Therefore technical problems of 
reliability were addressed by doing injections with micropipettes of different tip 
diameters. I found that the micropipette is easily blocked as it is lowered in the 
brain tissue when the tip diameter is greater than 30 ~Jm, which results in a failure 
to inject CTb. A tip diameter of less than 15 !Jm always results in a small injection 
sites and fewer detectable retrogradely labeled cells. According to luppi et al. 
(1990), CTb can be taken up and transported by damaged fibers passing in the 
areas of the micropipette tract. In other words, the smaller the pipette, the less 
likely it is that the CTb retrogradely labeled neurons result from CTb being taken 
up and transported by damaged fibers. Therefore, all of my CTb injections were 
done by using micropipettes with a relatively small tip of 15-25 ~Jm. 
I also tested a variety of concentrations of anti-CTb antibody (1 :10,000 to 
1 :40,000) to maximize neuronal labeling and minimize the background staining. 
lower concentration, for example 1:40,000, always gave darkly staining cells with 
clearly labeled cell bodies and dendrites. Higher concentration such as 1:10,000 
gave dark cells with a high background staining. Therefore, most of the CTb 
immunohistochemical reactions were done the concentration of 1 :40,000 in 
both the single- and the double-labeling experiments. It should be pointed out 
that even with higher background staining (1: 1 0,000), neurons were intensely 
stained black and could easily be distinguished from unlabeled neurons. 
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3.1.2 Single-labeling CTb Experiments 
CTb injections were done iontophoretically in various portions of the 
caudal half of the PAG and parts of the DR embedded in the PAG (Fig. 4A). The 
injections were subdivided into different groups according to the extent of 
diffusion of the tracer. For description of the data, I will consider injections that 
were largely confined to the PAGv! (n = 8), DR (n = 4) and injections involving the 
wings of the DR and parts of the PAGvi (n = 3). Control injections of CTb were 
also made in the dorsolateral region of the PAG (n = 4) and laterally outside of 
the PAG in the nucleus cuneiformis and deep mesencephalic nucleus (DpMe, n = 
4 ). In each group, the distribution of labeled cells was very similar for injections 
in specific regions of the PAG (for example, PAGvl compare to DR injections). 
Therefore, the data from one rat of each group (PAGvl, DR, PAGdl, outside PAG) 
is representative of each injection group. 
Figure 5A, 6F and 11A show the distribution of neurons labeled in the 
midbrain following an injection of CTb that was largely restricted to the PAGvL In 
this PAGvl injection, there was a little involvement of the lateral wing of the DR or 
the dorsolateral PAG, and no diffusion to the areas outside the PAG such as the 
nucleus cuneiformis or the DpMe. Retrogradely labeled neurons were found 
bilaterally in the rostrocaudal extent of the PAG as well as areas around the 
medial lemniscus. A large number of retrogradely labeled neurons were found in 
the SN below the medial lemniscus (Fig. 5, 6, 11 D, 11 E, 11 F) in both the SNC 
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Fig.5. Coronal sections of the midbrain following an immunohistochemical 
reaction to show a cholera toxin B injection in the ventrolateral periaquedudal 
gray (A) and the neurons in the substantia nigra (B, C, D) and the deep 
mesencephalic nucleus (C) that were retrogradely labeled for cholera toxin B 
(black). A large number of labeled neurons were found in the compact and 
reticular part of the substantia nigra and the deep mesencephalic nucleus. 
DpMe, deep mesencephalic nucleus; DR, dorsal raphe nucleus; ML, medial 
lemniscus; PAGvl, ventrolateral periaqueductal gray; SNR, reticular part of the 
substantia nigra. 
A B 
ML 
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Fig.6. A series of representative projection drawings of coronal sections through 
the midbrain showing the distribution of retrogradely labeled neurons following an 
injection of cholera toxin B into the ventrolateral periaqueductal gray (PAGvl). A 
large number of cells in the substantia nigra and a few in the ventral tegmental 
area project to the PAGvl. DpMe, deep mesencephalic nucleus; DR, dorsal 
raphe nucleus; IP, interpeduncular nudes; ml, medial lemniscus; PAGvl, 
ventrolateral periaqueductal gray; PAGdl, dorsolateral periaqueductal gray; pc, 
posterior commissure; SNC, compact part of the substantia nigra; SNR, reticular 
part of the substantia nigra; vr A, ventral tegmental area. 
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and SNR. Even though a number of CTb-labeled neurons were found scattered 
in various regions in the rostrocaudal extent of the vr A, most of them were 
located in the caudal aspect of the VT A (Fig. 6, 11 B, 11 E). A large number of 
neurons were also retrogradely labeled in the SNl and the DpMe located dorsal 
to the SNl (Fig. 5C, 6, 11 C). 
Figure 7 shows a representative case of retrograde labeling following an 
injection of CTb confined to the DR There are also some injections that are in 
the midline region of the DR (see Fig. 4 for example). As before, the projection is 
bilateral in origin with larger numbers of cells found in the VTA (Fig 78 to 7E) 
than what was observed following injections of CTb in the PAGvl (Fig. 6). This 
midline to lateral arrangement in the vr AISN was consistently seen in the 
injections that involved either the DR or PAGvl. Similar to the injection of the 
PAGvl, CTb-labeled neurons are more numerous in the caudal part of the VT A 
than in the rostral part. Neurons were also labeled in regions around the medial 
lemniscus including in the region of the SNC and the dorsomedial aspect of the 
SNR 
Injections of CTb into the dorsolateral region of the PAG resulted in the 
retrograde labeling of a few neurons in the 'VTA or SN (Fig. 8). As with injections 
in the PAGvl and DR, CTb injections in the dorsolateral PAG resulted in a large 
number of CTb-labeled neurons in the lateral region of the DpMe. A sparse 
distribution of CTb-labeled neurons was found in the SNl, and only a few isolated 
CTb-labeled neurons were found in the 'VT A or SNC/SNR (Fig. 8). 
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Fig. 7. Another series of representative projection drawings of coronal sections 
through the midbrain showing the distribution of retrogradely labeled neurons 
following an injection of cholera toxin B into the dorsal raphe nucleus. The dorsal 
raphe nudeus receives a dense projection from neurons in the ventral tegmental 
area and the compact part of the substantia nigra region. 
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Fig. 8. Drawings of midbrain sections showing the distribution of retrogradely 
labeled neurons following an injection of cholera toxin B (CTb) into the 
dorsolateral periaqueductal gray (PAGdl). Cells in the PAG area project to the 
injection site, and a large number of CTb-labeled cells in the deep 
mesencephalic nucleus and a few cells in the lateral part of the substantia nigra 
project to the PAGdl. 
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Control injections of CTb outside the PAG in the nucleus cuneiformis and 
DpMe resulted in retrograde labeling in mostly the SNL ipsilaterally and DpMe 
region immediately adjacent to the SNL (Fig. 9). CTb-labeled neurons were not 
seen in the rostrocaudal VT A. 
3.2 Double-labeling Experiments to Determine Neurotransmitter 
Double-labeling experiments were done with both immunohistochemistry 
and immunofluorescence to determine the putative neurotransmitter contained in 
the projection (dopamine or GABA). Double-labeling experiments using 
immunohistochemical protocols involve the use of DAB as a peroxidase substrate 
with and without nickel intensification (viewed with a light microscope). Double 
labeling with the immunofluorescent technique involved using Cy2 and Cy3 
conjugated secondary antibodies to show labeling of different substances (CTb 
and neurotransmitter, viewed under a fluorescent microscope). 
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Fig. 9. Drawings of midbrain sections showing the distribution of retrogradely 
labeled neurons following an injection of cholera toxin B into the deep 
mesencephalic nucleus and nucleus runeiformis. The ventral tegmental area 
does not project to nucleus cuneiformis area, and only a few isolated cells in the 
ipsilateral lateral part of the substantia nigra (SNL) and the deep mesencephalic 
nucleus region immediately adjacent to the SNL project to this area. 
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Successful double-labeling protocols with DAB immunohistochemistry 
have been used by previous investigators. For double-labeling using CTb, luppi 
et al. (1990) reported in a methodological paper that the histochemical identity of 
the retrogradely labeled cells can be identified based on the differential staining 
of CTb and neurotransmitters in the cell bodies. For example, CTb+ neurons 
stained by DAB-nickel intensfficaiton appear as black punctate granules because 
the CTb is concentrated in vesicles in the cell bodies. GAD+ neurons appear 
evenly brown when reacted with DAB without nickel intensification because 
GABA is homogenously distributed in the cell body. Therefore, the double-
labeled cells can be recognized by the presence of black punctate granules 
(CTb) over a brown diffusely stained cytoplasm (GAD). 
In my experiments, GAD immunohistochemistry resulted in a relatively 
high background staining. It was hard to distinguish which neurons were black 
CTb+ neurons and which were brown GAD+ neurons. In an attempt to decrease 
the high background staining, brain sections were pretreated with 1% solution of 
sodium borohydride in 0.1 M PBS for 10 min or 3% solution of hydrogen peroxide 
in 0.1 M PBS for 1 0 min. However, these approaches did not help in reducing the 
high GAD background staining. This suggested that the high background 
staining might be due to other factors. 
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Esclapez et al. (1994) reported that the relatively high background staining 
in the VTAISN was due to the high level of GAD in fibers and axon terminals in 
the ventral midbrain region, especially in the SNR region where GABA fibers 
were found in greatest numbers. I tried to use lower concentrations (from 1 :1 000 
to 1:1 0,000) of the primary GAD antibody in several of my double-labeling 
experiments. However, problems of clearly identifying double-labeled neurons 
were still present. The approach of demonstrating double-labeled CTb/GAD 
neurons using light microscope and DAB as a chromogen was considered 
inappropriate for the midbrain. Others have reported similar problems (Gonzalez-
Hernandez, and Rodriguez, 2000; Rodriguez, et al., 2001 ). 
Glutamic acid decarboxylase (GAD) is the enzyme responsible for the 
synthesis of GABA in nervous system. There are two isoforms that have been 
identified in the central nervous system, GAD65 and GAD67, each of which is 
encoded by a different gene. There are many differences between these two 
GAD proteins including amino acid sequence, molecular size, their interaction 
with the co-factor pyridoxal 5' -phosphate, and their regulatory control (Erlander 
and Tobin, 1991 ). GAD65 is localized in membrane-associated neuronal 
compartments such as synaptic vesicles (Mclaughlin et al., 1975; Reetz et al., 
1991) and ~~~ synaptic-like microvesicles (Reetz et al., 1991 ), whereas GAD67 
is a soluble cytosolic protein (Christgau et al., 1992; Solimena et al., 1993). In 
many brain regions, the two isoforms GAD65 and GAD67 are not evenly 
distributed: GAD65 is predominantly present in the axon terminals while GAD67 
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is more highly concentrated in the cell bodies (Esclapez eta!., 1994; Dirkx et al., 
1995). Gonzalez-Hernandez and Rodriguez (2000) have reported that no 
GAD65 labeled cells were found in the SN, which suggested that this GAD 
isoform was localized in axonal terminals. Using detergent Triton X-1 00 in GAD 
immunohistochemistry resulted in a decreased staining of cell bodies and an 
increased staining of axon terminals (Esclapez et al., 1994). This observation 
suggests that, because Triton X-100 increases the membrane permeability, more 
GAD antibodies penetrate and bind to the membrane-associated GAD65 in the 
synaptic vesicles or plasma membranes than those that bind to the soluble 
GAD67 in cytoplasm. I observed during my experiments that a low concentration 
of Triton X-100 is necessary for CTb antibodies to penetrate adequately. 
Therefore, a lower concentration of 0.01% Triton X-100 was used for CTb/GAD 
double-labeling immunofluorescent experiments. 
Problems with identifying double-labeled CTbiTH neurons also occurred 
when double-labeling experiments were attempted due to the very high density of 
TH immunoreactive neurons and fibers in the VT A and SN. TH is found in very 
high concentration in dopamine neurons and labeling with TH immunohisto-
chemistry produces intensely stained neurons which obscured the CTb labeling. 
Results of double-labeling experiments with DAB immunohisto-chemistry are not 
presented here because of the numerous methodological problems associated 
with the technique. This is largely due to the chemical nature of the VT AISN and 
not the technique itself, which has been successfully used in other regions of the 
brain. 
3.2.2.1 FluroGold Experiments 
In double-labeling experiments using FluroGold (FG), FG-Iabeled neurons 
appeared whitish blue when examined under the UV filter (see Fig. 108), and Cys 
conjugated donkey anti-rabbit immunoreaded GAD+ neurons appeared red (Fig. 
1 OA) under green filter. As described above, the FG-Iabeled cells were whitish 
blue while the GAD+ neurons could not be observed under UV filter. But under 
the U-MNG2 filter, GAD+ and FG-Iabeled neurons both appeared red, because 
FG fluoresces under a wide spectrum and can be seen with the U-MNG2 filter 
cube. Therefore, it was difficult to tell if a cell is a GAD+ neuron when the same 
neuron contains a large amount of FG. 
In addition, cells that are considered double-labeled should not only have 
the same location in the sections, but also the same size and shape. looking for 
double-labeled neurons required switching filters several times to make sure that 
the neuron was double-labeled. However, FG fades very quickly when examined 
with fluorescent microscope. Therefore, it was difficult to examine the tissue for 
double-labeled neurons without having the fluorescent probes fade because of 
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Fig. 1 0. Series of photomicrographs showing glutamic acid decarboxylase 
(GAD)+ neurons (A) and FluroGold-labeled neurons (B) in the ventral tegmental 
area. Panel C represents a merged image from panels A and B, and shows 
neurons that were double labeled for FluroGold and GAD (arrows). 
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the time it took to make a positive identification. This approach would likely lead 
to both false positive and false negative identification of double-labeled neurons. 
Because of these limitations, the decision was made not to use FG as a 
retrograde tracer for the immunofluorescent experiments. 
3.2.2.2 CTb Experiments 
Immunohistochemical experiments were done with a variety of GAO and 
TH antibodies. Polycional antibodies against GAD (catalog number AB108, 
AB1151, Chemicon international, Temecula, CA; catalog number 228485, Alpha 
Diagnostic, San Antonio, TX, USA) resulted in labeling of neurons in the VT AISN. 
However, the background staining with these GAD antibodies interfered with the 
visualization of cell body staining. Polyclonal antibody immunohistochemistry 
against TH (Serotec, Raleigh, NC) resulted in inconsistent outcomes and weak 
cell body staining. Use of monoclonal antibodies against GAD and TH 
(Chemicon International, Temecula, CA and Sigma, respectively) resulted in very 
strong cell body staining with low background. After several experiments to 
standardize the protocols the decision was made to use monoclonal antibodies at 
lower concentrations (GAO, 1:500 and TH, 1:40,000), which gave the best 
labeling for the immunofluorescent experiments. 
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Fig. 11. Photomicrograph of cholera toxin B (CTb) injections in the ventrolateral 
periaqueductal gray (A) and retrogradely CTb labeled neurons in relation to 
tyrosine hydroxylase (TH) labeled neurons. These plates were produced by 
merging two images taken under different filters to show the green Cy2-labeled 
CTb and red Cy3-labeled TH. A few CTb-labeled neurons were found in the 
ventral tegmental area (B, E) whereas, a large number of CTb-labeled neurons 
were found in the ventral region of the oompact part of the substantia nigra (D, E, 
F) where TH-Iabeled neurons are located and in the reticular part of the 
substantia nigra (B, C, D) immediately ventral to the TH-Iabeled neurons. There 
are no neurons that are double-labeled for CTb and TH. DpMe, deep 
mesencephalic nucleus; DR, dorsal raphe nucleus; Ml, medial lemniscus; 
PAGvl, ventrolateral periaqueductal gray; PAGdl, dorsolateral periaquedudal 
gray; SNC, oompact part of the substantia nigra; SNR, reticular part of the 
substantia nigra; VT A, ventral tegmental area. 
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Figure 48 illustrates the location of the CTb injections used for these 
double-labeling immunofluorescent experiments (n = 8). The injections were 
restricted to either the PAGvl or the DR, or involved a combination of these 
regions. Figure 11 shows the distribution of CTb-labeled neurons in the VT A 
(Fig. 11 B, 11 E) and SN (Fig. 11 D, 11 E, 11 F) following injections of CTb in the 
PAGvi/DR region (Fig. 11A) relative to TH+ neurons. CTb-labeled neurons that 
project to the PAGvi/DR were found interspersed with TH+ neurons in the VTA 
and SN. A considerable overlap in the location of the CTb-labeled and TH+ 
neurons was found in the transition zone between the SNC and SNR (Fig. 7F). 
However, when sections were examined at higher magnification, CTb-labeled 
neurons that were double labeled for TH were not observed (in 4 rats with CTb 
injections in the PAGvi/DR). Counts for CTb and TH double-labeled cells are not 
reported here because there was no evidence of double labeling for these 
markers. 
Tissue sections immunoreaded for both CTb and GAD neurons showed a 
proportion of neurons double labeled for both CTb and GAD (see Fig. 12 for 
example). Double-labeled neurons (those that were retrogradely labeled by CTb 
and labeled for GAD) were counted in four representative levels of the VTAISN in 
4 rats, which had injections limited to the PAGvi/DR. The numbers of 
CTb+/GAD+ neurons were 47/15 (32%) for the VTA; 198175 (38%) for the SNR; 
7817 (9%) for the SNC; 167/19 ( 11%) for the DpMe. It is possible that this 
represents an underestimation of the total number of CTb+/GAD+ neurons 
Fig.12. Photomicrographs of cholera toxin B (CTb) and glutamic acid 
decarboxylase (GAD) labeled neurons in the reticular portion of the substantia 
nigra following an injection of CTb into the ventrolateral periaqueductal gray 
(PAGvl, Fig. 11A). Plates A and D show CTb-labeled neurons viewed with a 
filter to show Cy2-labeled CTb neurons. Plates B and E show the same region 
as A and D but viewed with a filter to show Cy3-labeled GAD+ neurons. Plates C 
and F show merged images (A and B) and (D and E), respectively. Small arrows 
indicate double-labeled neurons whereas the large arrow heads indicate single 
CTb or GAD labeling. 
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making up the projection because a number of CTb+ neurons were weakly 
stained for GAD and were not considered as double-labeled neurons (see Fig. 12 
for examples). 
3.3 Physiological Experiments 
Picrotoxin is a pharmaceutical agent that selectively blocks the chloride 
channels by interacting with the GABA-receptor-ionophore complex. Injections of 
picrotoxin in the PAGvi/DR produced no immediate cardiovascular responses. 
However, it did result in a trend towards an increase in MAP that did not reach 
significance level (pre-picrotoxin 82.8 ± 4.2 mmHg; 5 min post-picrotoxin 99.7 ± 
6.5 mmHg; 30 min post-picrotoxin 94.2 ± 7.1 mmHg; n = 5) which was more 
apparent in some experiments (Fig. 13). In some cases, brief increases in 
respiratory activity following injections of picrotoxin occurred with the increases in 
MAP. The ANOVA indicated that injections of picrotoxin attenuated the 
depressor responses elicited by activation of the VTAISN with glutamate (F3,1s = 
3.238, P < 0.008; Fig. 9). The baseline response to VTAISN stimulation was 
attenuated by 69% at 5 min (P < 0.05, n = 5, Fig. 138, 13C) and by 74% at 30 
min (P < 0.05, n = 5, Fig. 138, 13C) post-picrotoxin administration. Restimulation 
of the same site in the VTAISN at 60 min post-picrotoxin resulted in depressor 
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response of similar magnitude as the baseline response (Fig. 138, 13C). 
Stimulation of the VfAISN produced small and inconsistent changes in HR 
responses that were unaffected by picrotoxin injections in the PAGviiDR (data not 
shown). The sites of the picrotoxin injections were verified on histological 
sections to be located in the caudal portion of the PAGvi/DR region (Fig. 13A). 
Control injections of saline in the PAGvi/DR had no effect on the cardiovascular 
depressor responses elicited from repeated stimulation of the same site in the 
VfAISN (n = 5; Fig. 138). 
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Fig. 13. Effects of picrotoxin on cardiovascular depressor responses from 
stimulation of the ventral tegmental area/substantia nigra (VT AISN). A:. Drawings 
of the midbrain showing the site of injections of glutamate in the VT AISN (A) or 
injections of picrotoxin/saline in ventrolateral periaqueductal gray/dorsal raphe 
nucleus (PAGvi/DR) (B) for the picrotoxin (triangle) and control saline (circle) 
experiments. B: Histogram shows the effect at 5, 30 and 60 min compared with 
baseline responses after the administration of picrotoxin (n = 5) or saline (n = 5) 
in the PAG/DR on the depressor response elicited from stimulation of the 
VTAISN. * P<0.05. C: A representative experiment showing the effect of 
microinjections of picrotoxin in the PAGIDR on the magnitude of the arterial 
pressure response elicited from stimulation of the VT AISN. The tracings show 
the magnitude of the response to stimulation of the same site in the VT AISN at 5, 
30, and 60 min post-injection of picrotoxin in the PAGIDR. Note that the 
depressor response at 60 min post-picrotoxin was of similar magnitude as the 
pre-picrotoxin depressor response elicited by stimulation of the VT AISN. 
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Chapter4 
Discussion 
Four major observations can be made from results of the present study: 
1. the PAGvl and DR receive a substantial input from neurons in the 
VTA, SN, and DpMe. 
2. this projection does not appear to use dopamine as a transmitter 
substance (TH negative). 
3. a portion of VTA and SN neurons projecting to the PAGvi/DR likely use 
GABA as a transmitter substance (GAO positive). 
4. the cardiovascular depressor responses elicited by activation of 
neurons in the vr AISN appear to be mediated by GABA release in the 
PAGviiDR because picrotoxin injections in the PAGvi/DR blocked the 
responses. 
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4.1 Anatomical Experiments 
4.1.1. Projection from the VTAISN to the PAGvi/DR 
The neuronal connections between the VTAISN and the PAGviiDR have 
been reported in previous tract tracing studies, but the details of this projection 
have not been the subject of a detailed investigation (Sakai et al., 1977; 
Beckstead et ai., 1979; Simon et al., 1979; Beitz et al., 1982; Marchand et al., 
1983; Kalen et al., 1988; Peyron et al., 1995; Gervasoni et al., 2000; Kirouac & 
Pittman, 2000). Studies looking at afferent inputs to the PAG using older and 
likely less sensitive tract tracing methods reported a relatively weak projection 
from the VTAISN to the PAG region (Sakai et al., 1977; Beckstead et al., 1979; 
Simon et al., 1979; Beitz et ai., 1982; Marchand et al., 1983). More recent 
studies, which have used more sensitive tracing substances such as CTb or fast 
blue, reported a moderately dense projection between the VT AISN and the DR 
(Kalen et al., 1988; Gervasoni et al., 2000). In a recent investigation using an 
anterograde tracer to describe descending brainstem projection from the 
VT AISN, Kirouac and Pittman (2000) demonstrated the presence of a dense 
bilateral projection from the VTAISN to the PAGvl and the wings of the DR The 
present investigation was done to describe the location of neurons in the VT AISN 
that innervate to the PAGvi/DR and to identify the transmitter substance used by 
these neurons. 
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In the present investigation, we found that the projection from the VT AISN 
to the PAGvi/DR showed a weak topography with the VT A preferentially 
innervating the wings of the OR while the SN preferentially innervating the PAGvl. 
However, there was considerable overlap in this arrangement, with neurons in 
the VTA and SN innervating both the PAGvl and the DR. A large number of 
neurons in the DpMe were also consistently found to send projections to both the 
PAGvl and the DR. Recent studies looking at afferent projections to the DR 
reported that neurons located in both the vr A and the SN innervated the DR 
(Kalen et al., 1988; Gervasoni et al., 2000). In contrast to a substantial 
innervation of the PAGvi/DR, neurons in the vr A and SN did not appear to 
innervate the dorsolateral regions of the PAG. 
A finding worth noting in the present study was the large number of 
neurons in the DpMe innervating both the PAGvl and DR. labeled fibers were 
reported in the PAG following injections of tritiated amino adds in the DpMe 
(Veazey and Severin, 1980a, b). However, identification of fiber terminals cannot 
be made using tritiated amino acids as an anterograde tracer. Therefore, the 
present study extends the work of Veazey and Severin (1980a, b) by 
demonstrating that a large number of neurons of the DpMe provide fiber 
terminals to the PAGvi/DR. 
The OpMe, also termed the midbrain reticular formation, central tegmental 
field, nucleus mesencephalirus profundus, or runeiformis/subcuneiformis 
complex (Huber et al., 1943; Olszewski and Baxter, 1954; Taber, 1962; Valverde, 
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1962), is a large midbrain region that composed of small, medium, and large-
sized neurons (Huber et al., 1943). The DpMe is located ventrally to the superior 
colliculus, dorsally to the SN, laterally to the red nucleus and the PAG, and 
medially to the medial geniculate nucleus (Veazey and Severin, 1980a, b, 1982; 
Hay-Schmidt and Mikkelsen, 1992; Yasui et al., 1994). The DpMe has been 
divided into a lateral division that sends ascending fibers to the basal ganglia and 
a medial division that sends descending projections to different nuclei of the 
caudal brainstem (Veazey and Severin, 1980a, b, 1982; Hay-Schmidt and 
Mikkelsen, 1992; Yasui et al., 1994). 
The DpMe has been considered to be involved in nociception, 
cardiovascular regulation (Nestianu and Mihailescu, 1985; Gonzalez-lima, 1988; 
Wang et al., 1992), and basal ganglia functions (Rodriguez et al., 2001). Both 
the SN and the DpMe contain GABA neurons (Mugnaini and Oertel, 1985; Appell 
and Behan, 1990; Esclapez et al., 1993). It is known that the SNR contains 
GABA neurons and is considered an important output nucleus of the basal 
ganglia (Albin et al., 1989; Alexander and Crutcher, 1990; Obeso et al., 1997). 
Recently, some studies have shown that the DpMe receives inputs from striatum 
as well (Rodriguez et al., 2001). Several studies also reported that the DpMe 
projects to the ventral thalamus and different midbrain and brainstem nuclei such 
as the superior colliclulus, pedunculopontine tegmental nucleus, medullar 
reticular nucleus, and central gray (Veazey and Severin, 1980a, b, 1982). These 
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data suggest that the DpMe may play a role in the basal ganglia similar to that of 
the SNR. 
A small proportion of neurons ( 11%) in the DpMe projecting to the 
PAGvi/DR were found to be GAD+. This suggests that the projection from the 
DpMe to the PAGviiDR uses more than one neurotransmitter because GABA 
only forms a portion of the projection. It should also be pointed out that the 
anatomy and function of the OpMe have not been the subject of much 
investigation except for recent studies (Rodriguez et al., 2001; Gonzalez-
Hernandez et al., 2002). This may be an area of interest for future anatomical 
and physiological studies. 
4.1.2. Putative neurotransmitters 
Axons and terminals immunoreactive for dopamine have been described 
in the PAGviiDR (Kitahama et al., 2000). The location of dopamine neurons 
innervating the DR is likely to be regions of the hypothalamus and not the VT A or 
the SN (Kalen et al., 1988; Peyron et al., 1995). However, the source of 
dopamine neurons projecting to the PAGvl may not be the same as the source of 
projections to the DR Based on our tract-tracing experiments that showed 
labeled neurons in the VT A and SNC (see Fig. 2 for example) following injections 
of CTb into the PAGvl, we examined the possibility that dopamine neurons in the 
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VT A or SN project to the PAGvl. Despite the apparent overlap of CTb neurons 
projecting to the PAGvi/DR and neurons stained with TH (Fig. 7), we did not find 
CTb neurons that were also labeled with TH. These results are consistent with 
previous studies reporting that the sources of dopamine fibers innervating the DR 
are the A 11 and A 13 dopamine neurons located in the dorsal hypothalamus 
(Kalen et al., 1988; Peymn et al., 1995). 
Neurons in the VT AISN have been shown, using immunohistochemical 
techniques, to contain the neuropeptides neumtensin and cholecystokinin 
(Seroogy et al., 1988). However, these neuropeptides are not found in isolation 
in subpopulations of neurons in the VT AISN but are colocalized with dopamine in 
the same neuron (Seroogy et al., 1988). Since CTb+ cells were always found to 
be TH-, we would not expect CTb+ cells to contain either neurotensin or 
cholecystokinin. 
The other well-known neuronal type found in the region of the VT AISN is 
GABA (Gonzalez-Hernandez and Rodriguez, 2000). Therefore, the experiments 
addressed the possibility that GABA neurons in the VT AISN innervate the 
PAGviiDR A proportion of neurons in the VTA (32%), SNC (9%), and SNR 
(38%) that projected to the PAGvi/DR contained GAD, an enzyme involved in the 
synthesis of GABA. This observation is consistent with a recent study showing 
that as many as 58% of the neurons in the VT A that projected to the DR were 
GAD positive (Gervasoni et al. 2000). The differences in the total number of 
GAO positive cells projecting to the PAGvi/DR noted by the two studies may be 
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due to the sensitivity of the different techniques used to show GAD positive 
neurons. For example, our study used immunofluorescence with a Cy3 
conjugated secondary antibody whereas Gervasoni et al. (2000) used the avidin-
biotin complex method and the chromogen DAB. In the present study cells that 
were not clearly labeled for GAD in our counts were not included in order to 
eliminate the possibility of including false positives. Therefore, the counts in our 
study likely represent an underestimation of the proportion of GABA neurons in 
the VTAISN that project to the PAGvi/DR. 
A novel opioid peptide recently identified as having biological activities in 
the brain is nociceptinlorphanin FQ (Darland et al., 1998; Taylor and Dickenson, 
1998). This opioid peptide has been shown to be present in some neurons in the 
VT AISN (Anton et al., 1996) and could therefore be a potential candidate as a 
transmitter substance innervating the PAG. The PAG also contains a dense 
network of nociceptinlorphanin FQ fibers and terminals (Anton et al., 1996; 
Norton et al., 2002). In preliminary experiments done in our laboratory, we were 
unable to detect this opioid peptide using immunohistochemistry when done on 
midbrain tissue from colchicine treated rats (unpublished observations). 
Therefore, we cannot eliminate the possibility that a number of neurons in the 
VTAISN innervating the PAG use nociceptinlorphanin FQ as a transmitter 
substance. It may be necessary to use in situ hybridization of mRNA to examine 
this question appropriately (Neal et al., 1999; Norton et al., 2002). It has also 
been reported that GAD and mRNA for nooception/orphanin FQ colocalize in the 
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same neurons (Norton et ai., 2002). It would be of interest to determine if GABA 
neurons in the VT AJSN that project to the PAGvi/DR also contain this opioid 
peptide. This is of particular importance since nociceptinlorphanin FQ in the 
PAG appears to play an important role in pain modulation (Darland et al., 1998; 
Taylor and Dickenson, 1998). 
4.2 Physiological Experiments and Anatomical Connections 
Kirouac and Pittman (2000) provided evidence that the cardiovascular 
depressor responses produced by stimulation of the vr AJSN were mediated by a 
projection to the PAGvi/DR. This conclusion was based on experiments showing 
that reversible block of nerve impulse transmission and synaptic transmission in 
the PAGvi/DR with lidocaine and cobalt chloride, respectively, attenuated the 
depressor responses elicited by stimulation of the VT AISN (Kirouac and Pittman, 
2000). In the present study, blocking of chloride channels associated with GABA 
receptors with injections of picrotoxin into the PAGviiDR region almost eliminated 
the cardiovascular depressor responses to stimulation of the VT AJSN. Therefore, 
the results of the physiological experiments support our hypothesis that a 
functional pathway exists between these two midbrain regions. In addition, the 
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results of our physiological experiments are consistent with our anatomical 
evidence showing that GAD+ neurons in the VT AISN project to the PAGvi/DR 
Moreover, the physiological and anatomical experiments support the view that 
activation of a VTAISN GABAergic projection to the PAGviiDR mediates the 
cardiovascular depressor responses produced by stimulation of the VTAISN. 
However, it is also possible that the depressor responses from VT AISN 
stimulation were eliminated because picrotoxin inhibited GABA intemeurons in 
the PAGviiDR, which are known regulators of PAGvl projection neurons 
(Reichling and Basbaum, 1990). 
It is plausible that stimulation of the VT AISN produces hypotensive 
responses by activating a projection from the PAGvl to the ventromedial and 
ventrolateral medulla (Lovick, 1993; Bandler and Shipley, 1994; Behbehani, 
1995; Bandler et al., 2000). The ventromedial and ventrolateral medulla project 
to preganglionic sympathetic neurons in the intermediolateral cell oolumn and 
activation of these descending pathways can produce vasodilation in the 
circulation by inhibiting preganglionic sympathetic motor neurons (Dampney, 
1994; Sun, 1995; see Fig. 3). Therefore, stimulation of the VT AISN may in tum 
activate output neurons in the PAGvl that exert influence on cardiovascular 
regulatory centers in the medulla. 
Numerous anatomical and physiological investigations have demonstrated 
that the neural circuitry in the PAGvl also mediates antinodception (see review by 
Behbehani, 1995). The rostral ventromedial medulla and A5 cell group project 
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directly to the dorsal hom of the spinal oord where transmission of nociceptive 
information is inhibited (Dampney, 1994; Sun, 1995; see Fig. 3). In addition, a 
projection between the VTAISN and the PAGviiDR may also influence neurons in 
the PAGvl that are involved in the regulation of nociception. 
4.3 functional Considerations 
4.3.1 Role of the PAGvl in Nociception and Cardiovascular Regulation 
It is well known that the PAG is a key component of the brain's descending 
pain modulatory circuit (Basbaum and Fields, 1984; Behbehani, 1995; Fields et 
al., 1991). Activation of neurons in all areas of the PAG by a variety of methods, 
including electrical stimulation and injections of excitatory amino acids, produces 
antinociception and inhibition of nociceptive neurons in the spinal cord. 
Furthermore, microinjection of morphine into the PAGvl produces potent 
antinociception (Yaksh et al., 1976; Bennett and Mayer, 1979). In fad, the PAGvl 
is a key site in the brain where systemic morphine is believed to produce its 
analgesic effect (Basbaum and Fields, 1984; Behbehani, 1995; Fields et al., 
1991 ). Eledrophysiological experiments have shown that a proportion of 
neurons in the PAGvl respond to noxious or nociceptive stimuli applied to the 
body surface (Eickhoff et al., 1978; Sanders et al., 1980; Nakahama et al., 1981). 
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This is also supported by studies using e-ros expression as an indication of 
neuronal activation, which show that noxious stimulations of deep tissue and 
viscera activate neurons in the PAGvl (Clement et al., 1996; Keay and Bandler, 
1993; Keay et al, 1994). In summary, nociceptive neurons in the PAGvl are 
believed to be part of a negative feedback system in which nociceptive stimuli 
activate the PAGvl circuitry involved in the production of antinociception. 
A large amount of literature has accumulated on the role of the PAG in 
regulating emotional expression and cardiovascular function (Bandler et al., 
1991; Carrive and Bandler, 1991; Bandler and Shipley, 1994; Dampney, 1994; 
Behbehani, 1995; Sun, 1995). As presented in the introduction, PAG is arranged 
in functional columns. Activation of the PAGvl with electrical and chemical 
stimulation produces hypotension and bradycardia (Lovick, 1993; Bandler and 
Shipley, 1994). Neurons in the PAGvl are activated by decreases in blood 
pressure indicating that this area is involved in the regulation of the baroreceptor 
reflexes (li and Dampney, 1995; Murphy et al., 1995; Tassoreli and Joseph, 
1995). Keay and Bandler (1998) have hypothesized that the PAGvl is the region 
of the brain where neurons are excited by deep somatic and visceral nociceptive 
inputs and may be involved in the production of cardiovascular responses to pain 
(Bandler and Shipley, 1994). Therefore, previous experiments suggested that 
the PAGvl is a critical brain region in which deep pain and haemorrhage inputs 
may be integrated to produce hypotension and bradycardia. 
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4.3.2 VTAISN Regulation of the PAGviiDR 
This study describes a GABAergic projection between the VT AISN and the 
PAGvi/DR. It is recognized that GABAergic neurons in the VTA project to other 
regions of the brain and do not function exclusively as interneurons within the 
VT A (Carr and Sesack, 2000; Steffensen et al., 1998). In fad, a population of 
GABAergic neurons in the VT A appears to play a significant role in the rewarding 
properties of electrical brain self-stimulation (Steffensen et al., 2001) and may 
project to forebrain sites through the internal capsule (Steffensen et al., 1998). 
Therefore, it is likely that GABA projection neurons in the VT A or SN exert an 
influence on other sites in the brain including the PAGviiDR. 
A connection between the VTAISN and the PAGvi/DR is of potential 
importance because of the numerous studies that support a role for the VTA and 
SN in the modulation of pain and arterial blood pressure, two functions regulated 
by the PAGvi/DR. However, a functional link between these midbrain regions 
has not received much consideration. Evidence for this functional link has been 
provided by the physiological experiments in this paper as well as previous 
observations (Kirouac and Pittman, 2000) showing that stimulation of the VT AISN 
produces cardiovascular depressor responses that are mediated by a pathway to 
the PAGvi/DR. There is also considerable evidence that the VT A and SN play a 
role in pain modulation (Juma et al., 1978; Bames et al., 1979; Baumeister and 
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Frye, 1986; Frye et al., 1986; Baumeister et al., 1987, 1988, 1989, 1990, 1993; 
Hebert et al., 1990; Morgan and Franklin, 1990; Baumeister, 1991; Altier and 
Stewart, 1993, 1996, 1997, 1998). At the present, there is no evidence that 
antinociception elicited by activation of neurons in the VT AISN is mediated by a 
projection to the PAGviiDR. Considering the fact that a significant GABAergic 
projection exists between the VTAISN and the PAGvi/DR and that GABA is an 
important regulator of PAG pain modulating mechanisms (Reichling and 
Basbaum, 1990; Williams and Beitz, 1990; Osborne et al., 1996; Roychowdhury 
and Fields, 1996; Hall and Behbehani, 1998), it is plausible that a GABAergic 
connection between the VT AISN and the PAGvi/DR plays an important role in the 
modulation of pain. In addition to their role in pain modulation, there are 
numerous studies demonstrating that the VT AISN receives nociceptive 
information (Barasi, 1979; Tsai et al., 1980; Tsai, 1989; Ma et al., 1993; Gao et 
al., 1996; Smith et al., 1997; Ohtori et al., 2000) suggesting that pain may 
activate neural circuitry in the VT AISN, which may in tum modulate the 
transmission of pain. It is also possible that the VT AISN region modulates 
neural mechanisms in the PAGviiDR involved in the production of behavioral and 
autonomic responses to pain and stress (Lovick, 1993; Behbehani, 1995; Bandler 
and Shipley, 1994; Bandler et al., 2000) including changes in blood pressure 
(Kirouac and Pittman, 2000). In this way, the VTAISN would serve as a regulator 
of the PAGvi/DR circuitry involved in responses to pain and stress including the 
modulation of blood pressure and pain transmission. 
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